$RVPH Cashflow Statement | Understand Stock

$RVPH

$0.35 +$0.00 (0.0%) Close

$RVPH Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation
Change in fair value of warrant liabilities
Noncash interest expense
Issuance of stock in exchange for services
Stock-based compensation expense

Changes in operating assets and liabilities:
Deferred cost
Prepaid clinical trial costs (current and non-current)
Prepaid expenses and other current assets
Accounts payable
Accrued interest
Accrued expenses and other current liabilities
Net cash used in operating activities

Cash flows from financing activities
Issuance of common stock in lieu of deferred compensation
Proceeds from business combination, net of costs
Proceeds from issuance of Units in public offering, net
Proceeds from issuance of short-term debt
Repayment of short-term debt
Proceeds from issuance of common stock in ATM offering, net of transaction costs
Proceeds from exercise of common stock warrants
Common Stock Warrants
Total proceeds from exercise of common stock warrants
Proceeds from issuance of convertible promissory notes
Net cash provided by financing activities
Net decrease in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period

Supplemental disclosures of cash flow information:
Cash paid for taxes
Cash paid for interest
Conversion of convertible promissory notes into common stock
Payment of certain deferred costs from proceeds from business combination
Noncash Investing and Financing Activities:
Settlement of bonuses in form of stock options
Warrant modification recorded in stockholders' equity
Issuance of warrants
Common Stock Warrants
Prefunded Warrants
Underwriter Warrants
Transaction costs related to offerings included in accounts payable and accrued expenses

Comments